Versant Capital Management, Inc Meridian Bioscience Inc Transaction History

Versant Capital Management, Inc

$431 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$18.01 - $28.32 $16,371 - $25,742	-909 Closed	0 $0
Q1 2021 Apr 27, 2021	SELL	$19.76 - $29.89 $7,291 - $11,029	-369 Reduced 28.87%	909 $24,000
Q4 2020 Feb 08, 2021	SELL	$15.73 - $21.66 $928 - $1,277	-59 Reduced 4.41%	1,278 $23,000
Q3 2020 Nov 02, 2020	SELL	$13.54 - $26.41 $67 - $132	-5 Reduced 0.37%	1,337 $22,000
Q1 2020 Apr 17, 2020	BUY	$5.57 - $11.5 $7,474 - $15,433	1,342 New	1,342 $11,000
Q2 2019 Jul 16, 2019	SELL	$10.88 - $17.6 $2,273 - $3,678	-209 Closed	0 $0
Q1 2019 Apr 23, 2019	BUY	$15.51 - $17.61 $3,195 - $3,627	206 Added 6866.67%	209 $3,000
Q1 2019 Apr 23, 2019	SELL	$15.51 - $17.61 $13,881 - $15,760	-895 Reduced 99.67%	3 $3,000
Q4 2018 Jan 29, 2019	SELL	$14.52 - $19.72 $261 - $354	-18 Reduced 1.97%	898 $15,000
Q3 2018 Oct 15, 2018	SELL	$14.85 - $16.35 $4,247 - $4,676	-286 Reduced 23.79%	916 $13,000
Q2 2018 Jul 06, 2018	SELL	$13.8 - $16.8 $2,911 - $3,544	-211 Reduced 14.93%	1,202 $19,000
Q1 2018 Apr 19, 2018	SELL	$13.8 - $16.2 $386 - $453	-28 Reduced 1.94%	1,413 $20,000
Q4 2017 Apr 19, 2018	BUY	$13.55 - $15.8 $2,560 - $2,986	189 Added 15.1%	1,441 $20,000
Q3 2017 Apr 23, 2018	SELL	$13.45 - $14.35 $11,203 - $11,953	-833 Reduced 39.95%	1,252 $17,000
Q2 2017 Apr 23, 2018	BUY	N/A	1,136 Added 119.7%	2,085 $32,000
Q1 2017 Apr 23, 2018	BUY	N/A	644 Added 211.15%	949 $13,000
Q3 2016 Apr 23, 2018	SELL	N/A	-46 Reduced 13.11%	305 $5,000
Q2 2016 Apr 23, 2018	SELL	N/A	-3 Reduced 0.85%	351 $6,000
Q1 2016 Apr 23, 2018	SELL	N/A	-1,543 Reduced 81.34%	354 $7,000
Q4 2015 Apr 23, 2018	BUY	N/A	1,897	1,897 $38,000

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Account